Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 13

1.

Long-term outcome of fludarabine-based reduced-intensity allogeneic hematopoietic cell transplantation for debilitating paroxysmal nocturnal hemoglobinuria.

Pantin J, Tian X, Geller N, Ramos C, Cook L, Cho E, Scheinberg P, Vasu S, Khuu H, Stroncek D, Barrett J, Young NS, Donohue T, Childs RW.

Biol Blood Marrow Transplant. 2014 Sep;20(9):1435-9. doi: 10.1016/j.bbmt.2014.05.012. Epub 2014 May 17.

2.

Magnetic nanosensor for detection and profiling of erythrocyte-derived microvesicles.

Rho J, Chung J, Im H, Liong M, Shao H, Castro CM, Weissleder R, Lee H.

ACS Nano. 2013 Dec 23;7(12):11227-33. doi: 10.1021/nn405016y. Epub 2013 Dec 2.

3.

Rapid donor T-cell engraftment increases the risk of chronic graft-versus-host disease following salvage allogeneic peripheral blood hematopoietic cell transplantation for bone marrow failure syndromes.

Pantin J, Tian X, Shah AA, Kurlander R, Ramos C, Cook L, Khuu H, Stroncek D, Leitman S, Barrett J, Donohue T, Young NS, Geller N, Childs RW.

Am J Hematol. 2013 Oct;88(10):874-82. doi: 10.1002/ajh.23526. Epub 2013 Sep 3.

4.

Allogeneic stem cell transplantation in paroxysmal nocturnal hemoglobinuria.

Peffault de Latour R, Schrezenmeier H, Bacigalupo A, Blaise D, de Souza CA, Vigouroux S, Willemze R, Terriou L, Tichelli A, Mohty M, de Guibert S, Marsh JC, Passweg J, Yves Mary J, Socié G.

Haematologica. 2012 Nov;97(11):1666-73. doi: 10.3324/haematol.2012.062828. Epub 2012 Jun 11.

5.

Paroxysmal nocturnal hemoglobinuria from bench to bedside.

Pu JJ, Brodsky RA.

Clin Transl Sci. 2011 Jun;4(3):219-24. doi: 10.1111/j.1752-8062.2011.00262.x. Review.

6.

Phenotypic and functional characterization of a mouse model of targeted Pig-a deletion in hematopoietic cells.

Visconte V, Raghavachari N, Liu D, Keyvanfar K, Desierto MJ, Chen J, Young NS.

Haematologica. 2010 Feb;95(2):214-23. doi: 10.3324/haematol.2009.011650. Epub 2009 Aug 13.

7.

Glycosylphosphatidylinositol-anchored protein deficiency confers resistance to apoptosis in PNH.

Savage WJ, Barber JP, Mukhina GL, Hu R, Chen G, Matsui W, Thoburn C, Hess AD, Cheng L, Jones RJ, Brodsky RA.

Exp Hematol. 2009 Jan;37(1):42-51. doi: 10.1016/j.exphem.2008.09.002. Epub 2008 Nov 14.

8.

Reduced intensity HLA-haploidentical BMT with post transplantation cyclophosphamide in nonmalignant hematologic diseases.

Brodsky RA, Luznik L, Bolaños-Meade J, Leffell MS, Jones RJ, Fuchs EJ.

Bone Marrow Transplant. 2008 Oct;42(8):523-7. doi: 10.1038/bmt.2008.203. Epub 2008 Jul 14.

9.

Regression of human kidney cancer following allogeneic stem cell transplantation is associated with recognition of an HERV-E antigen by T cells.

Takahashi Y, Harashima N, Kajigaya S, Yokoyama H, Cherkasova E, McCoy JP, Hanada K, Mena O, Kurlander R, Tawab A, Srinivasan R, Lundqvist A, Malinzak E, Geller N, Lerman MI, Childs RW.

J Clin Invest. 2008 Mar;118(3):1099-109. doi: 10.1172/JCI34409. Erratum in: J Clin Invest. 2008 Apr;118(4):1584. Abdul, Tawab [corrected to Tawab, Abdul].

10.

Advances in the diagnosis and therapy of paroxysmal nocturnal hemoglobinuria.

Brodsky RA.

Blood Rev. 2008 Mar;22(2):65-74. Epub 2007 Dec 3. Review.

11.

A unique population of effector memory lymphocytes identified by CD146 having a distinct immunophenotypic and genomic profile.

Elshal MF, Khan SS, Raghavachari N, Takahashi Y, Barb J, Bailey JJ, Munson PJ, Solomon MA, Danner RL, McCoy JP Jr.

BMC Immunol. 2007 Nov 13;8:29.

12.

Computation of plasma hemoglobin nitric oxide scavenging in hemolytic anemias.

Jeffers A, Gladwin MT, Kim-Shapiro DB.

Free Radic Biol Med. 2006 Nov 15;41(10):1557-65. Epub 2006 Aug 25.

13.

Diagnosis and management of paroxysmal nocturnal hemoglobinuria.

Parker C, Omine M, Richards S, Nishimura J, Bessler M, Ware R, Hillmen P, Luzzatto L, Young N, Kinoshita T, Rosse W, Socié G; International PNH Interest Group.

Blood. 2005 Dec 1;106(12):3699-709. Epub 2005 Jul 28. Review. No abstract available.

Supplemental Content

Support Center